InvestorsHub Logo
Followers 31
Posts 901
Boards Moderated 0
Alias Born 12/23/2009

Re: itsabouttime post# 267482

Wednesday, 06/29/2016 4:48:19 AM

Wednesday, June 29, 2016 4:48:19 AM

Post# of 345957
Isn't it te other way around? Shift MERCK - AZN

Planned studies include bavituximab in combination with pembrolizumab (AZN ?, it should be MERCK) in hepatocellular carcinoma,and durvalumab (MERCK?) in NSCLC
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News